Cognitive Research Corporation
24
0
1
18
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
16.7%
4 terminated/withdrawn out of 24 trials
81.8%
-4.7% vs industry average
21%
5 trials in Phase 3/4
67%
12 of 18 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (24)
Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults
Role: collaborator
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
Role: collaborator
Phase I Single Ascending Dose and Multiple Ascending Doses of Oral AFA-281 in Healthy Volunteers
Role: collaborator
A Study of ANAVEX3-71 in Adults With Schizophrenia
Role: collaborator
Safety and Efficacy of HB-1 for Panic Disorder
Role: collaborator
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia
Role: collaborator
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)
Role: collaborator
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
Role: collaborator
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
Role: collaborator
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
Role: collaborator
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
Role: collaborator
Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim
Role: collaborator
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
Role: collaborator
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
Role: collaborator
Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS
Role: collaborator
Study of BXCL501 In Agitation Associated With Delirium in ICU Patients
Role: collaborator
Driving Simulation to Assess Non-Sedative Effects of Tolperisone
Role: collaborator
Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
Role: collaborator
The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants
Role: collaborator
Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function
Role: collaborator